BioSeek
DiscoveRx Acquires BioSeek
NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.
BioSeek Gets $47M Contract for ToxCast Program
NEW YORK (GenomeWeb News) – BioSeek today said that the US Environmental Protection Agency has extended the firm's contract to participate in the ToxCast screening program.
A research team led by scientists at proteomics firm Cellzome has developed a selective inhibitor to the PI3 kinase isoform PI3Kγ.
Cellzome to Use BioSeek Platform in Inflammatory Diseases Research
Cellzome will use the BioMap platform in its inflammatory disease drug discovery projects.
Jun 14, 2010
Asterand Subsidiary to Screen Amylin Library
May 4, 2010
Eisai to Use BioSeek's Drug Modeling Platform
Mar 23, 2010
BioSeek to Collaborate with Ono
Nov 18, 2009
Asterand to Acquire BioSeek
Jun 30, 2009
BioSeek to Continue in ToxCast Program
Jun 10, 2009